NovaBridge Biosciences (NBP) Preferred Shares (2019 - 2020)
NovaBridge Biosciences (NBP) posted quarterly Preferred Shares of $188.8 million for Q4 2020, little changed year-on-year from $188.8 million in Q1 2020, and little changed on a QoQ basis from $188.8 million in Q2 2020.
NovaBridge Biosciences (NBP) Preferred Shares (2019 - 2020) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Preferred Shares for 2 consecutive years, with $188.8 million the latest figure, recorded in Q4 2020.
- Quarterly Preferred Shares changed 0.0% year-over-year to $188.8 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $188.8 million (changed 0.0% YoY) and the FY2020 annual result came in at $188.8 million, changed 0.0% from the prior year.
- Preferred Shares steadied at $188.8 million in Q4 2020 per NBP's latest filing, from $188.8 million in the prior quarter.
- Over the last five years, Preferred Shares for NBP reached as high as $188.8 million in Q4 2019 and fell as low as $188.8 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | NovaBridge Biosciences | 389.86 Mn | 389.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 188.82 Mn |
| Jun 30, 2020 | 188.82 Mn |
| Dec 31, 2019 | 188.82 Mn |